Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia

Clinical trial NCT02165397 · COMPLETED

Trial details

NCT number: NCT02165397
Sponsor: Pharmacyclics LLC.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Waldenström's Macroglobulinemia

Start date: 2014-07-07
Primary completion: 2019-11-07
Enrollment: 181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.